Sixty-five clinical isolates of Streptococcus pneumoniae, all collected in Italy between 1999 and 2002 and resistant to both tetracycline (MIC, >8 g/ml) and erythromycin (MIC, >1 g/ml), were investigated. Of these strains, 11% were penicillin resistant and 23% were penicillin intermediate. With the use of the erythromycinclindamycin-rokitamycin triple-disk test, 14 strains were assigned to the constitutive (cMLS) phenotype of macrolide resistance, 44 were assigned to the partially inducible (iMcLS) phenotype, 1 was assigned to the inducible (iMLS) phenotype, and 6 were assigned to the efflux-mediated (M) phenotype. In PCR assays, 64 of the 65 strains were positive for the tetracycline resistance gene tet(M), the exception being the one M isolate susceptible to kanamycin, whereas tet(K), tet(L), and tet(O) were never found. All cMLS, iMcLS, and iMLS isolates had the erythromycin resistance gene erm(B), and all M phenotype isolates had the mef(A) or mef(E) gene. No isolate had the erm(A) gene. The int-Tn gene, encoding the integrase of the Tn916-Tn1545 family of conjugative transposons, was detected in 62 of the 65 test strains. Typing assays showed the strains to be to a great extent unrelated. Of 16 different serotypes detected, the most numerous were 23F (n ‫؍‬ 13), 19A (n ‫؍‬ 10), 19F (n ‫؍‬ 9), 6B (n ‫؍‬ 8), and 14 (n ‫؍‬ 6). Of 49 different pulsed-field gel electrophoresis types identified, the majority (n ‫؍‬ 39) were represented by a single isolate, while the most numerous type included five isolates. By high-resolution restriction analysis of PCR amplicons with four endonucleases, the tet(M) loci from the 64 tet(M)-positive pneumococci were classified into seven distinct restriction types. Overall, a Tn1545-like transposon could reasonably account for tetracycline and erythromycin resistance in the vast majority of the pneumococci of cMLS, iMcLS, and iMLS phenotypes, whereas a Tn916-like transposon could account for tetracycline resistance in most M phenotype strains.
In Streptococcus pneumoniae, tetracycline resistance is predominantly due to ribosomal protection, i.e., the production of cytoplasmic proteins--encoded by tet(M) or, less often, other tet genes-capable of interacting with the ribosome and making it insensitive to tetracycline inhibition (3, 38) . An effluxmediated mechanism reducing the intracellular tetracycline concentration to subtoxic levels is less common in streptococci, where this mechanism is due to membrane proteins encoded by the gene tet(K) or tet(L) (3) .
Pneumococcal resistance to macrolides is due to either target site modification or active efflux (40) . The former, prevalent mechanism usually depends on a posttranscriptional, methylase-mediated modification of 23S rRNA encoded by the erm(B) gene (19, 40) . erm(B)-associated coresistance to macrolide, lincosamide, and streptogramin B (MLS) antibiotics can be expressed either constitutively, with high-level resistance to all MLS antibiotics (cMLS phenotype), or inducibly (iMLS phenotype). More often, pneumococcal strains appear inducibly resistant to only 16-membered macrolides and constitutively resistant to lincosamides (iMcLS phenotype) (22) . Another methylase first described (31) and then found to be extensively present (15, 17) in Streptococcus pyogenes, mediated by a gene originally called erm(TR) and now designated erm(A) according to current nomenclature (30) , has only occasionally been reported in S. pneumoniae (2, 35) . Recently, mutations in 23S rRNA or ribosomal proteins leading to macrolide resistance in clinical isolates of S. pneumoniae have also been described (10, 37) . A macrolide efflux mechanism, first demonstrated with S. pneumoniae and S. pyogenes and then with other streptococci, is associated with a resistance pattern (M phenotype) characterized by low-level resistance to only 14-and 15-membered macrolides among MLS antibiotics (34) . M phenotype resistance is mediated by mef genes, two variants of which, mef(A) and mef(E)-originally discovered in S. pyogenes (4) and S. pneumoniae (36) , respectively-have 90% identity (36) and have been regarded as a single gene class designated mef(A) (30) . However, the two variants have recently been shown to be carried by different genetic elements in S. pneumoniae (9) , and due to a number of important differences in the properties of mef(A)-and mef(E)-carrying pneumococci (9, 22) , it has been recommended that the distinction between the two genes be maintained. A novel erythromycin efflux system, not associated with mef(A) or with other known macrolide efflux genes, has lately been described in erm(A)-positive strains of S. pyogenes with inducible, high-level resistance to erythromycin (14) . However, its presence in S. pneumoniae and other streptococci has not yet been addressed.
In streptococci, drug resistance determinants occur more frequently on conjugative transposons than on plasmids. In particular, in S. pneumoniae the association of erythromycin resistance and tetracycline resistance may be due to Tn1545 and related conjugative transposons, which encode erythromycin resistance via erm(B) and tetracycline resistance via tet (M) and also kanamycin resistance via aphA3 (8) . These transposons belong to a larger class of conjugative transposons, typically represented by Tn916, which encode tet(M)-mediated resistance to tetracycline but not resistance to erythromycin or kanamycin (6) . An integrase gene usually called int-Tn, related to the second of the 24 open reading frames of Tn916, is characteristic of the Tn916-Tn1545 family of conjugative transposons (6) .
In this study, a collection of clinical S. pneumoniae isolates resistant to both tetracycline and erythromycin were typed and investigated for a number of phenotypic and genotypic characteristics inherent to either resistance.
MATERIALS AND METHODS
Bacterial strains. Sixty-five clinical isolates of S. pneumoniae, all resistant to both tetracycline (MIC, Ն8 g/ml) and erythromycin (MIC, Ն1 g/ml), were tested. All strains, collected from several Italian laboratories between 1999 and 2002, were isolated from upper respiratory tract specimens (the vast majority), sputum, blood, or cerebrospinal fluid. Strain identification was confirmed in our laboratory by conventional tests, such as susceptibility to optochin and solubility in bile, and by the API system (Biomérieux, Marcy-l'Etoile, France).
Antibiotics and susceptibility tests. Tetracycline, erythromycin, minocycline, and penicillin were purchased from Sigma Chemical Co., St. Louis, Mo. Broth microdilution MICs were determined and MIC breakpoints of tetracycline and erythromycin were interpreted as recommended by the National Committee for Clinical Laboratory Standards (24) . Mueller-Hinton II broth (BBL Microbiology Systems, Cockeysville, Md.) supplemented with 3% lysed horse blood was used as the test medium. The inoculum was 5 ϫ 10 5 CFU/ml, and S. pneumoniae ATCC 49619 was used for quality control. Kanamycin susceptibility was determined by a standard agar diffusion test (25) using 30-g commercial disks (Oxoid Ltd., Basingstoke, United Kingdom) with the following zone diameter breakpoints: susceptible, Ն18 mm; intermediate, 14 to 17 mm; resistant, Յ13 mm.
Determination of the macrolide resistance phenotype. Test strains were assigned to the constitutive (cMLS), the partially inducible (iMcLS), the inducible (iMLS), or the efflux-mediated (M) macrolide resistance phenotype on the basis of the triple-disk (erythromycin plus clindamycin and rokitamycin) test, as described previously (23) .
Gene detection by PCR. Tetracycline resistance genes tet(K) and tet(L) were detected by using the primer pairs described by Trzcinski et al. (39) , and tet(M) and tet(O) were detected by using those described by Corso et al. (7) and Olsvik et al. (26) , respectively. Erythromycin resistance genes erm(A) and erm(B) were detected by using the oligonucleotide primers designated III 8 and III 10 by Seppälä et al. (31) and the primer pair developed by Sutcliffe et al. (33) , respectively. The mef gene was detected by using the primer pair described by Sutcliffe et al. (33) ; mef(A) and mef(E) were then distinguished by PCR restriction fragment length polymorphism analysis of the 348-bp amplicon with BamHI (New England Biolabs, Beverly, Mass.), which has no restriction site in mef(E) and one in mef(A), generating two fragments of 284 and 64 bp (22) . The integrase gene int-Tn, associated with the Tn916-Tn1545 family of conjugative transposons, was detected by using the primer pair described by Poyart-Salmeron et al. (27) . DNA preparation and amplification and electrophoresis of PCR products were carried out by adapting established methods (16) to the procedures described for the individual primer pairs.
Serotyping. All isolates were serotyped by the capsular swelling test using specific antisera (Statens Seruminstitut, Copenhagen, Denmark). Serotypes were indicated with conventional capsular type designations.
PFGE. SmaI macrorestriction fragment patterns were analyzed by pulsed-field gel electrophoresis (PFGE); macrorestriction and PFGE were performed, and the relevant patterns were analyzed and compared as recently described elsewhere (29) . For clusters with at least two isolates, types were designated with lowercase letters in order of size.
HRRA. High-resolution restriction analysis (HRRA) of the tet(M) gene was carried out essentially as described by Doherty et al. (12) . Briefly, a 10-l aliquot of the PCR product obtained by using the primer pair described by Corso et al. (7) from each tet(M)-positive isolate was digested with the following restriction endonucleases: AciI, MseI, RsaI, and TaqI (New England Biolabs). Restriction fragments were separated by agarose (4%) gel electrophoresis and visualized by staining with ethidium bromide. The molecular size marker (100-bp DNA ladder) was from M-Medical Genenco, Florence, Italy. Each restriction pattern yielded by each endonuclease was assigned a number; restriction genotypes were determined on the basis of the combined restriction patterns of all four enzymes and lettered with capitals in order of size.
RESULTS
Antibiotic susceptibility. The distribution of MICs of tetracycline, erythromycin, and penicillin for the 65 tetracyclineand erythromycin-resistant isolates of S. pneumoniae is summarized in Table 1 . Forty-three strains were susceptible to penicillin (MIC, Ͻ0.12 g/ml), 15 were intermediate, and seven were resistant (the MIC for five of these strains was 2 g/ml and that for the other two was 4 g/ml). All the strains but one were resistant to kanamycin according to the results of the disk tests.
Macrolide resistance phenotypes. On the basis of the erythromycin-clindamycin-rokitamycin triple-disk test, 14 of the 65 test strains were assigned to the cMLS phenotype, 44 were assigned to the iMcLS phenotype, 1 was assigned to the iMLS phenotype, and 6 were assigned to the M phenotype. These findings, together with the ranges of MICs of erythromycin, are summarized in Table 2 .
Genotypic strain characterization. As shown in Table 3 , the tetracycline resistance genes tet(K), tet(L), and tet(O) were not found. In contrast, 64 of the 65 test strains were positive for tet(M), the exception being one M phenotype isolate (MIC of penicillin, 0.25 g/ml; MIC of tetracycline, 16 g/ml; MIC of minocycline, 0.25 g/ml; MIC of erythromycin, 16 g/ml), the only isolate susceptible to kanamycin, which was negative for all four tetracycline resistance genes tested. All cMLS and iMcLS isolates as well as the iMLS isolate had the erm(B) gene, and all six M phenotype isolates had the mef gene 
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gene were also int-Tn positive, whereas the isolate lacking tet(M) as well as the other tetracycline resistance genes tested was also int-Tn negative. Typing. Sixteen different serotypes, of which 11 were represented by at least two isolates, were detected. The most numerous was 23F (n ϭ 13), followed by 19A (n ϭ 10), 19F (n ϭ 9), 6B (n ϭ 8), and 14 (n ϭ 6).
Forty-nine PFGE types, of which 10 were represented by at least two isolates, were detected. Type a, the most numerous, included five isolates.
The distribution of serotypes and PFGE types among the 65 erythromycin-and tetracycline-resistant S. pneumoniae isolates and their associations with the characteristics described above (macrolide resistance phenotypes, tetracycline and erythromycin resistance genes, and the int-Tn gene) are summarized in Table 3 .
Restriction types of the tet(M) gene. With HRRA of allelic variation within tet(M), endonucleases MseI and TaqI each yielded consistently the same fingerprinting profiles from the PCR amplicons of all strains, whereas AciI and RsaI produced five and two distinct profiles, respectively (Fig. 1) . Altogether, the tet(M) loci from the 64 tet(M)-positive pneumococci analyzed fell into seven restriction types (A to G). Their distribution is reported in Table 3 . Over half (31 of 59) of the strains with the erm(B) gene (cMLS, iMcLS, and iMLS phenotypes) had restriction type A, whereas four of the five strains with the mef gene (M phenotype) exhibited restriction type B. Restriction types A and B are shown in Fig. 2 .
DISCUSSION
In clinical isolates of S. pneumoniae, tetracycline resistance is frequently associated with erythromycin resistance. In one large U.S. survey carried out from 1999 to 2000, Ͼ60% of multiresistant pneumococci exhibiting erythromycin resistance were also resistant to tetracycline (11) ; in Europe, associations of Ͼ80% in erythromycin-resistant pneumococci isolated in Spain (32) and Italy (21) have recently been reported. This association may reflect the widespread presence in pneumococcal populations of transposons, typified by Tn1545, thought to result from the insertion over time of resistance determinants, such as erm(B) for erythromycin and aphA3 for kanamycin, into primitive gram-positive conjugative transposons carrying tet(M) and the integrase gene int-Tn, typified by Tn916 (3, 6) .
Among the 65 tetracycline-and erythromycin-resistant clinical strains of S. pneumoniae investigated in this study, the presence of Tn1545-like transposons could reasonably account for tetracycline and erythromycin resistance in the vast majority (at least 57 of 59) of the strains of the cMLS, iMcLS, and iMLS phenotypes, i.e., those sharing tet(M), erm(B), kanamycin resistance, and the int-Tn gene. The remaining two isolates shared tet(M), erm(B), and kanamycin resistance but were int-Tn negative. However, tet(M) was also associated with int-Tn in five of the six strains of the M phenotype, i.e., strains lacking erm genes and expressing erythromycin resistance due to mef-mediated active efflux. Unlike erm(B) in pneumococci with constitutive or inducible MLS resistance, the mef gene in M phenotype pneumococci is not known to be linked to tetracycline resistance, which in these strains could be due to a Tn916-like transposon. Similar findings-i.e., M phenotype 
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loci (no. of strains) (9, 22) . However, in the case of associated tetracycline resistance, whereas in S. pyogenes isolates the mef gene is associated with tet(O) (Giovanetti et al., 12th, ECCMID), this study shows that in pneumococci it is associated with tet(M).
The 65 tetracycline-and erythromycin-resistant S. pneumoniae strains tested were distributed over 16 serotypes and 49 PFGE types. These findings, in addition to the other phenotypic and genotypic differences, indicate that the test strains were substantially unrelated. This suggests a spread of resistance due to horizontal transfer of transposons or resistance determinants rather than to clonal dissemination. The most numerous serotypes (23F, 19A, 19F, 6B, 14, etc.) are essentially those that have more frequently been seen to combine macrolide and erythromycin resistance in other studies in Italy (18, 21) and in other European countries (1, 28) . The rates of both penicillinresistant (11%) and penicillin-intermediate (23%) isolates in our collection of tetracycline-and erythromycin-resistant pneumococci were higher than those recently reported among clinical S. pneumoniae isolates in Italy (13, 21) .
